Cornerstone Wealth Group’s Boston Scientific BSX Stock Holding History

Cornerstone Wealth Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.82M	Buy	64,233 +59,722	+1,324%	+$4.78M	0.25%	103
2025 Q4	$430K	Buy	4,511 +470	+12%	+$46.1K	0.03%	225
2025 Q3	$395K	Buy	4,041 +203	+5%	+$21K	0.03%	226
2025 Q2	$412K	Buy	3,838 +809	+27%	+$81.9K	0.03%	206
2025 Q1	$306K	Buy	3,029 +267	+10%	+$26.9K	0.03%	221
2024 Q4	$247K	Buy	2,762 +205	+8%	+$18K	0.02%	238
2024 Q3	$214K	Sell	2,557 -132	-5%	-$10.4K	0.02%	245
2024 Q2	$207K	Buy	+2,689	New	+$197K	0.02%	239
2021 Q4	–	Sell	-108,777	Closed	-$4.72M	–	151
2021 Q3	$4.72M	Buy	+108,777	New	+$4.81M	0.83%	29

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cornerstone Wealth Group's BSX Position: Q1 2026 in Review

Cornerstone Wealth Group increased its Boston Scientific (BSX) stake by 1,324% in Q1 2026, buying an estimated $4.78M and bringing the position to 64,233 shares worth $3.82M. The position accounts for 0.25% of the portfolio, ranked #103.

Cornerstone Wealth Group first reported a position in BSX in Q3 2021 and has held it in 9 quarters since. The position peaked at $4.72M in Q3 2021. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Cornerstone Wealth Group held 64,233 shares of Boston Scientific worth $3.82M as of Q1 2026.
Cornerstone Wealth Group bought 59,722 Boston Scientific shares in Q1 2026, an estimated $4.78M.
Boston Scientific made up 0.25% of Cornerstone Wealth Group's portfolio in Q1 2026, its #103 holding.
Cornerstone Wealth Group first reported a position in Boston Scientific in Q3 2021 and has held it in 9 quarters since.
Cornerstone Wealth Group's Boston Scientific position peaked at $4.72M in Q3 2021.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Cornerstone Wealth Group's 13F filing for Q1 2026, filed 22 Apr 2026.